Back

KuLGaP: A Selective Measure for Assessing Therapy Response in Patient-Derived Xenografts

Ortmann, J.; Rampasek, L.; Tai, E.; Mer, A. S.; Shi, R.; Mascaux, C.; Fares, A.; Pham, N.-A.; Beri, G.; Eeles, C.; Tkachuk, D.; Ho, C.; Sakashita, S.; Weiss, J.; Jiang, X.; Liu, G.; Cescon, D. W.; O'Brien, C.; Guo, S.; Tsao, M.-S.; Haibe-Kains, B.; Goldenberg, A.

2020-09-09 bioinformatics
10.1101/2020.09.08.287573 bioRxiv
Show abstract

Quantifying response to drug treatment in mouse models of human cancer is important for treatment development and assignment, and yet remains a challenging task. A preferred measure to quantify this response should take into account as much of the experimental data as possible, i.e. both tumor size over time and the variation among replicates. We propose a theoretically grounded measure, KuLGaP, to compute the difference between the treatment and control arms. KuLGaP is more selective than currently existing measures, reduces the risk of false positive calls and improves translation of the lab results to clinical practice.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.